Economic implications of 21-gene recurrence score assay: US multicenter experience
- PMID: 20498396
- DOI: 10.1200/JCO.2010.28.8944
Economic implications of 21-gene recurrence score assay: US multicenter experience
Comment on
-
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.J Clin Oncol. 2010 Apr 1;28(10):1671-6. doi: 10.1200/JCO.2008.20.2119. Epub 2010 Jan 11. J Clin Oncol. 2010. PMID: 20065191
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
